The Patent Finder

Micrologix Biotech Inc.

Also on record
Records under this name other than patents Micrologix Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Micrologix Biotech Inc.

PatentTitleStatus Expires Confidence
US 8,138,144Antimicrobial cationic peptides and formulations thereof
Formerly held
Term ended
Term ended Oct 9, 2023 · From the USPTO record
Term endedTerm ended Oct 9, 2023From the USPTO record
US 8,933,029Antimicrobial and anti-inflammatory peptides
Formerly held
Lapsed on the fee record
Ended Jan 13, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jan 13, 2023From the USPTO record
US 6,835,536Antimicrobial cationic peptides and formulations thereof
Formerly held
Term ended
Term ended Nov 19, 2022 · From the USPTO record
Term endedTerm ended Nov 19, 2022From the USPTO record
US 6,881,831Nucleic acid-based compounds and methods of use thereof
Formerly held
Term ended
Term ended May 15, 2022 · From the USPTO record
Term endedTerm ended May 15, 2022From the USPTO record
US 6,620,796Combinatorial library synthesis and pharmaceutically active compounds produced thereby
Formerly held
Term ended
Term ended Nov 8, 2020 · From the USPTO record
Term endedTerm ended Nov 8, 2020From the USPTO record
US 6,180,604Compositions and methods for treating infections using analogues of indolicidin
Formerly held
Term ended
Term ended Aug 20, 2017 · From the USPTO record
Term endedTerm ended Aug 20, 2017From the USPTO record
US 6,503,881Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
Formerly held
Term ended
Ended no later than Aug 20, 2017 · From the USPTO record
Term endedEnded no later than Aug 20, 2017From the USPTO record
US 7,390,787Compositions and methods for treating infections using analogues of indolicidin
Formerly held
Term ended
Ended no later than Aug 20, 2017 · From the USPTO record
Term endedEnded no later than Aug 20, 2017From the USPTO record
US 6,737,403Derivatives of laspartomycin and preparation and use thereof
Formerly held
Lapsed on the fee record
Ended May 18, 2016 · From the USPTO record
Lapsed on the fee recordEnded May 18, 2016From the USPTO record
US 7,309,759Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
Formerly held
Lapsed on the fee record
Ended Dec 18, 2015 · From the USPTO record
Lapsed on the fee recordEnded Dec 18, 2015From the USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited